WATSON 408 (Lisinopril 20 mg)

Pill imprint WATSON 408 has been identified as Lisinopril 20 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; heart failure (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 408

Lisinopril 20 mg WATSON 408
Lisinopril 20 mg WATSON 408
Lisinopril
Imprint:
WATSON 408
Strength:
20 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0408
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0350 McKesson Packaging Services
43063-0007 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)